_id
691485d5ccc777a4e85d95f2
Ticker
NXL
Name
Nexalin Technology Inc.
Exchange
NASDAQ
Address
1776 Yorktown, Houston, TX, United States, 77056
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://www.nexalin.com
Description
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.
Last Close
0.579
Volume
72214
Current Price
0.7124
Change
0.0246
Last Updated
2026-01-05T11:55:05.528Z
Image
data:image/webp;base64,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
Ipo Date
2022-09-16T00:00:00.000Z
Market Cap
10866620
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.999
Sentiment Sources
1
Rating
4
Target Price
4
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
18149
Cost Of Revenue
454768
Gross Profit
-436619
Operating Expenses
1909011
Operating Income
-2345631
Interest Expense
-
Pretax Income
-2276311
Net Income
-2276311
Eps
-0.1279269980579783
Dividends Per Share
-
Shares Outstanding
18651939
Income Tax Expense
-
EBITDA
-2270838
Operating Margin
-12924.298859441291
Total Other Income Expense Net
69320
Cash
590075
Short Term Investments
3762602
Receivables
7925
Inventories
160225
Total Current Assets
4817378
Property Plant Equipment
-
Total Assets
5125940
Payables
67493
Short Term Debt
-
Long Term Debt
-
Total Liabilities
357524
Equity
4768416
Bs_currency_symbol
USD
Depreciation
5473
Change In Working Capital
-231435
Cash From Operations
-1466257
Capital Expenditures
3
Cash From Investing
1625012
Cash From Financing
0
Net Change In Cash
158755
Cf_currency_symbol
USD
PE
-
PB
2.658392864045419
ROE
-47.737256984289964
ROA
-44.4076793719786
FCF
-1466260
Fcf Percent
-80.79012617775084
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
3.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
5.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
18149
Quarters > 0 > income Statement > cost Of Revenue
454768
Quarters > 0 > income Statement > gross Profit
-436619
Quarters > 0 > income Statement > operating Expenses
1909011
Quarters > 0 > income Statement > operating Income
-2345631
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-2276311
Quarters > 0 > income Statement > net Income
-2276311
Quarters > 0 > income Statement > eps
-0.1279269980579783
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
17793828
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2270838
Quarters > 0 > income Statement > operating Margin
-12924.298859441291
Quarters > 0 > income Statement > total Other Income Expense Net
69320
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
590075
Quarters > 0 > balance Sheet > short Term Investments
3762602
Quarters > 0 > balance Sheet > receivables
7925
Quarters > 0 > balance Sheet > inventories
160225
Quarters > 0 > balance Sheet > total Current Assets
4817378
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
5125940
Quarters > 0 > balance Sheet > payables
67493
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
357524
Quarters > 0 > balance Sheet > equity
4768416
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2276311
Quarters > 0 > cash Flow > depreciation
5473
Quarters > 0 > cash Flow > change In Working Capital
-231435
Quarters > 0 > cash Flow > cash From Operations
-1466257
Quarters > 0 > cash Flow > capital Expenditures
3
Quarters > 0 > cash Flow > cash From Investing
1625012
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
158755
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.1279269980579783
Quarters > 0 > ratios > PB
2.658392864045419
Quarters > 0 > ratios > ROE
-47.737256984289964
Quarters > 0 > ratios > ROA
-44.4076793719786
Quarters > 0 > ratios > FCF
-1466260
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-80.79012617775084
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
70588
Quarters > 1 > income Statement > cost Of Revenue
22838
Quarters > 1 > income Statement > gross Profit
47750
Quarters > 1 > income Statement > operating Expenses
1668608
Quarters > 1 > income Statement > operating Income
-1620858
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-1580987
Quarters > 1 > income Statement > net Income
-1580987
Quarters > 1 > income Statement > eps
-0.10058353563132656
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
15718149
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1575862
Quarters > 1 > income Statement > operating Margin
-2296.2231540771804
Quarters > 1 > income Statement > total Other Income Expense Net
39871
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
431320
Quarters > 1 > balance Sheet > short Term Investments
5361465
Quarters > 1 > balance Sheet > receivables
59841
Quarters > 1 > balance Sheet > inventories
172974
Quarters > 1 > balance Sheet > total Current Assets
6269111
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
6563982
Quarters > 1 > balance Sheet > payables
240580
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
600584
Quarters > 1 > balance Sheet > equity
5963398
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-1580987
Quarters > 1 > cash Flow > depreciation
5126
Quarters > 1 > cash Flow > change In Working Capital
119034
Quarters > 1 > cash Flow > cash From Operations
-917165
Quarters > 1 > cash Flow > capital Expenditures
5
Quarters > 1 > cash Flow > cash From Investing
-3919941
Quarters > 1 > cash Flow > cash From Financing
4646397
Quarters > 1 > cash Flow > net Change In Cash
-190709
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.10058353563132656
Quarters > 1 > ratios > PB
1.8777229605671129
Quarters > 1 > ratios > ROE
-26.51151239612047
Quarters > 1 > ratios > ROA
-24.085791216368357
Quarters > 1 > ratios > FCF
-917170
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-12.993284977616591
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
41015
Quarters > 2 > income Statement > cost Of Revenue
13558
Quarters > 2 > income Statement > gross Profit
27457
Quarters > 2 > income Statement > operating Expenses
2038682
Quarters > 2 > income Statement > operating Income
-2011225
Quarters > 2 > income Statement > interest Expense
370
Quarters > 2 > income Statement > pretax Income
-1988337
Quarters > 2 > income Statement > net Income
-1988337
Quarters > 2 > income Statement > eps
-0.14941679837989907
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
13307319
Quarters > 2 > income Statement > income Tax Expense
1048
Quarters > 2 > income Statement > EBITDA
-2006439
Quarters > 2 > income Statement > operating Margin
-4903.632817261978
Quarters > 2 > income Statement > total Other Income Expense Net
22888
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
622029
Quarters > 2 > balance Sheet > short Term Investments
1429050
Quarters > 2 > balance Sheet > receivables
14479
Quarters > 2 > balance Sheet > inventories
175253
Quarters > 2 > balance Sheet > total Current Assets
2620591
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
2900111
Quarters > 2 > balance Sheet > payables
181394
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
574736
Quarters > 2 > balance Sheet > equity
2325375
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-1988337
Quarters > 2 > cash Flow > depreciation
4786
Quarters > 2 > cash Flow > change In Working Capital
-60252
Quarters > 2 > cash Flow > cash From Operations
-1426214
Quarters > 2 > cash Flow > capital Expenditures
4
Quarters > 2 > cash Flow > cash From Investing
1473758
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
47544
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.14941679837989907
Quarters > 2 > ratios > PB
4.07681946163522
Quarters > 2 > ratios > ROE
-85.50607966457024
Quarters > 2 > ratios > ROA
-68.5607206069009
Quarters > 2 > ratios > FCF
-1426218
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-34.7730830184079
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
27179
Quarters > 3 > income Statement > cost Of Revenue
7496
Quarters > 3 > income Statement > gross Profit
19683
Quarters > 3 > income Statement > operating Expenses
2895079
Quarters > 3 > income Statement > operating Income
-2875396
Quarters > 3 > income Statement > interest Expense
370
Quarters > 3 > income Statement > pretax Income
-2833275
Quarters > 3 > income Statement > net Income
-2833275
Quarters > 3 > income Statement > eps
-0.3074376188994259
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
9215772
Quarters > 3 > income Statement > income Tax Expense
-4846
Quarters > 3 > income Statement > EBITDA
-2870955
Quarters > 3 > income Statement > operating Margin
-10579.476801942677
Quarters > 3 > income Statement > total Other Income Expense Net
42121
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
574485
Quarters > 3 > balance Sheet > short Term Investments
2905438
Quarters > 3 > balance Sheet > receivables
13043
Quarters > 3 > balance Sheet > inventories
174578
Quarters > 3 > balance Sheet > total Current Assets
3961141
Quarters > 3 > balance Sheet > property Plant Equipment
0
Quarters > 3 > balance Sheet > total Assets
4222732
Quarters > 3 > balance Sheet > payables
155949
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
546694
Quarters > 3 > balance Sheet > equity
3676038
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2833275
Quarters > 3 > cash Flow > depreciation
4441
Quarters > 3 > cash Flow > change In Working Capital
80058
Quarters > 3 > cash Flow > cash From Operations
-1134476
Quarters > 3 > cash Flow > capital Expenditures
16226
Quarters > 3 > cash Flow > cash From Investing
1627540
Quarters > 3 > cash Flow > cash From Financing
0
Quarters > 3 > cash Flow > net Change In Cash
493064
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.3074376188994259
Quarters > 3 > ratios > PB
1.7859760896922177
Quarters > 3 > ratios > ROE
-77.07414885265061
Quarters > 3 > ratios > ROA
-67.09578064627355
Quarters > 3 > ratios > FCF
-1150702
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-42.33790794363295
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
168721
Annuals > 0 > income Statement > cost Of Revenue
36593
Annuals > 0 > income Statement > gross Profit
132128
Annuals > 0 > income Statement > operating Expenses
7886774
Annuals > 0 > income Statement > operating Income
-7754646
Annuals > 0 > income Statement > interest Expense
3193
Annuals > 0 > income Statement > pretax Income
-7607182
Annuals > 0 > income Statement > net Income
-7607182
Annuals > 0 > income Statement > eps
-0.8254524960035904
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
9215772
Annuals > 0 > income Statement > income Tax Expense
-4851
Annuals > 0 > income Statement > EBITDA
-7739539
Annuals > 0 > income Statement > operating Margin
-4596.135632197533
Annuals > 0 > income Statement > total Other Income Expense Net
147464
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
574485
Annuals > 0 > balance Sheet > short Term Investments
2905438
Annuals > 0 > balance Sheet > receivables
13043
Annuals > 0 > balance Sheet > inventories
174578
Annuals > 0 > balance Sheet > total Current Assets
3961141
Annuals > 0 > balance Sheet > property Plant Equipment
0
Annuals > 0 > balance Sheet > total Assets
4222732
Annuals > 0 > balance Sheet > payables
155949
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
546694
Annuals > 0 > balance Sheet > equity
3676038
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-7607182
Annuals > 0 > cash Flow > depreciation
15107
Annuals > 0 > cash Flow > change In Working Capital
121654
Annuals > 0 > cash Flow > cash From Operations
-3944390
Annuals > 0 > cash Flow > capital Expenditures
170306
Annuals > 0 > cash Flow > cash From Investing
-577539
Annuals > 0 > cash Flow > cash From Financing
4516184
Annuals > 0 > cash Flow > net Change In Cash
-5745
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.8254524960035904
Annuals > 0 > ratios > PB
1.46056944112112
Annuals > 0 > ratios > ROE
-206.9396997528317
Annuals > 0 > ratios > ROA
-180.14834945717607
Annuals > 0 > ratios > FCF
-4114696
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-24.387574753587284
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
110748
Annuals > 1 > income Statement > cost Of Revenue
25688
Annuals > 1 > income Statement > gross Profit
85060
Annuals > 1 > income Statement > operating Expenses
5781356
Annuals > 1 > income Statement > operating Income
-5696296
Annuals > 1 > income Statement > interest Expense
38835
Annuals > 1 > income Statement > pretax Income
-4648709
Annuals > 1 > income Statement > net Income
-4648709
Annuals > 1 > income Statement > eps
-0.631873137920212
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
7357029
Annuals > 1 > income Statement > income Tax Expense
-4
Annuals > 1 > income Statement > EBITDA
-5692042
Annuals > 1 > income Statement > operating Margin
-5143.475277205909
Annuals > 1 > income Statement > total Other Income Expense Net
1047587
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
580230
Annuals > 1 > balance Sheet > short Term Investments
2368203
Annuals > 1 > balance Sheet > receivables
9369
Annuals > 1 > balance Sheet > inventories
156420
Annuals > 1 > balance Sheet > total Current Assets
3429892
Annuals > 1 > balance Sheet > property Plant Equipment
496
Annuals > 1 > balance Sheet > total Assets
3631916
Annuals > 1 > balance Sheet > payables
159534
Annuals > 1 > balance Sheet > short Term Debt
4463
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
425281
Annuals > 1 > balance Sheet > equity
3206635
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-4648709
Annuals > 1 > cash Flow > depreciation
4254
Annuals > 1 > cash Flow > change In Working Capital
-768862
Annuals > 1 > cash Flow > cash From Operations
-3835384
Annuals > 1 > cash Flow > capital Expenditures
109279
Annuals > 1 > cash Flow > cash From Investing
4452872
Annuals > 1 > cash Flow > cash From Financing
-200000
Annuals > 1 > cash Flow > net Change In Cash
417487
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.631873137920212
Annuals > 1 > ratios > PB
1.3366675955947591
Annuals > 1 > ratios > ROE
-144.9715667670315
Annuals > 1 > ratios > ROA
-127.99604946810443
Annuals > 1 > ratios > FCF
-3944663
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-35.61836782605555
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1321357
Annuals > 2 > income Statement > cost Of Revenue
363212
Annuals > 2 > income Statement > gross Profit
958145
Annuals > 2 > income Statement > operating Expenses
2791176
Annuals > 2 > income Statement > operating Income
-1833031
Annuals > 2 > income Statement > interest Expense
59382
Annuals > 2 > income Statement > pretax Income
-1697816
Annuals > 2 > income Statement > net Income
-1697816
Annuals > 2 > income Statement > eps
-0.23300645764079136
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
7286562
Annuals > 2 > income Statement > income Tax Expense
227997
Annuals > 2 > income Statement > EBITDA
-1827308
Annuals > 2 > income Statement > operating Margin
-138.7233730172845
Annuals > 2 > income Statement > total Other Income Expense Net
135215
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
162743
Annuals > 2 > balance Sheet > short Term Investments
6831192
Annuals > 2 > balance Sheet > receivables
4875
Annuals > 2 > balance Sheet > inventories
154370
Annuals > 2 > balance Sheet > total Current Assets
7425462
Annuals > 2 > balance Sheet > property Plant Equipment
6674
Annuals > 2 > balance Sheet > total Assets
7432136
Annuals > 2 > balance Sheet > payables
658367
Annuals > 2 > balance Sheet > short Term Debt
750797
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1953449
Annuals > 2 > balance Sheet > equity
5478687
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-1697816
Annuals > 2 > cash Flow > depreciation
535
Annuals > 2 > cash Flow > change In Working Capital
-634066
Annuals > 2 > cash Flow > cash From Operations
-2215699
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-6794879
Annuals > 2 > cash Flow > cash From Financing
8511543
Annuals > 2 > cash Flow > net Change In Cash
-499035
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.23300645764079136
Annuals > 2 > ratios > PB
0.7748482476184531
Annuals > 2 > ratios > ROE
-30.989468827111317
Annuals > 2 > ratios > ROA
-22.844253657360415
Annuals > 2 > ratios > FCF
-2215699
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-1.676836010253096
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
144065
Annuals > 3 > income Statement > cost Of Revenue
21442
Annuals > 3 > income Statement > gross Profit
122623
Annuals > 3 > income Statement > operating Expenses
6141224
Annuals > 3 > income Statement > operating Income
-6018601
Annuals > 3 > income Statement > interest Expense
82319
Annuals > 3 > income Statement > pretax Income
-6078004
Annuals > 3 > income Statement > net Income
-6078004
Annuals > 3 > income Statement > eps
-0.8348951319931521
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
7279961
Annuals > 3 > income Statement > income Tax Expense
82319
Annuals > 3 > income Statement > EBITDA
-5995148
Annuals > 3 > income Statement > operating Margin
-4177.698261201541
Annuals > 3 > income Statement > total Other Income Expense Net
-59403
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
661778
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
16303
Annuals > 3 > balance Sheet > inventories
31410
Annuals > 3 > balance Sheet > total Current Assets
752659
Annuals > 3 > balance Sheet > property Plant Equipment
1039
Annuals > 3 > balance Sheet > total Assets
753698
Annuals > 3 > balance Sheet > payables
843794
Annuals > 3 > balance Sheet > short Term Debt
778045
Annuals > 3 > balance Sheet > long Term Debt
22916
Annuals > 3 > balance Sheet > total Liabilities
2435639
Annuals > 3 > balance Sheet > equity
-1681941
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-6078004
Annuals > 3 > cash Flow > depreciation
537
Annuals > 3 > cash Flow > change In Working Capital
522641
Annuals > 3 > cash Flow > cash From Operations
-1076791
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-6794879
Annuals > 3 > cash Flow > cash From Financing
1660133
Annuals > 3 > cash Flow > net Change In Cash
583342
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.8348951319931521
Annuals > 3 > ratios > PB
-2.5216730423956606
Annuals > 3 > ratios > ROE
361.3684427693956
Annuals > 3 > ratios > ROA
-806.4243238007796
Annuals > 3 > ratios > FCF
-1076791
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-7.474341443098601
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.1279269980579783
Valuation > metrics > PB
2.658392864045419
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-47.737256984289964
Profitability > metrics > ROA
-47.252073638398315
Profitability > metrics > Net Margin
-125.42349440740537
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.07497751873997571
Risk > metrics > Interest Coverage
-428.5823131737621
Risk > final Score
-1654
Risk > verdict
High
Liquidity > metrics > Current Ratio
71.37596491488006
Liquidity > metrics > Quick Ratio
69.00201502378025
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
39.231805383647796
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-1205
Prev Risks > 1
-21683
Prev Risks > 2
-31025
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:19:31.072Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-12-03
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.13
Earnings History > 0 > eps Estimate
-0.12
Earnings History > 0 > eps Difference
-0.01
Earnings History > 0 > surprise Percent
-8.3333
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-09-03
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.1
Earnings History > 1 > eps Estimate
-0.14
Earnings History > 1 > eps Difference
0.04
Earnings History > 1 > surprise Percent
28.5714
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-28
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.15
Earnings History > 2 > eps Estimate
-0.13
Earnings History > 2 > eps Difference
-0.02
Earnings History > 2 > surprise Percent
-15.3846
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-26
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.25
Earnings History > 3 > eps Estimate
-0.12
Earnings History > 3 > eps Difference
-0.13
Earnings History > 3 > surprise Percent
-108.3333
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-27
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.23
Earnings History > 4 > eps Estimate
-0.12
Earnings History > 4 > eps Difference
-0.11
Earnings History > 4 > surprise Percent
-91.6667
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-09-25
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.1713
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-03-31
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.14
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2023-12-31
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.105
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-09-30
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.3098
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-06-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.1129
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-10
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.1
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-27
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.1
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.03
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.03
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-09-19
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.06
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.06
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-31
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.08
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.08
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-01-04
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.06
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.06
Earnings History > 15 > surprise Percent
-
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ADrug-free brain stimulation eases adult ADHD and calms overactive activity Stock Titan
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$4
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Nexalin Technology Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.13
EPS Estimate
-0.12
EPS Difference
-0.01
Surprise Percent
-8.3333%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.